Monograph Title | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date Sort ascending | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
DOFETILIDE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change β-[(p-Methanesulfonamidophenethyl)methylamino]methane sulfono-p-phenetidide to: N-{4-[2-(Methyl{2-[4-(methylsulfonamido)phenoxy]ethyl}amino)ethyl]phenyl}methanesulfonamide |
CALCIUM UNDECYLENATE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Solution A: Change 0.15 N hydrochloric acid in water prepared as follows. Transfer 150 mL of hydrochloric acid to a 500-mL volumetric flask, dilute with water to volume, and mix well. to: 0.15 N hydrochloric acid in water prepared as follows.… Read More |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IDENTIFICATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In A. Spectroscopic Identification Tests <197>, Infrared Spectroscopy: 197K: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
TETRACYCLINE HYDROCHLORIDE | SPECIFIC TESTS/Bacterial Endotoxins Test <85> | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change Where the label states tetracycline hydrochloride must be subjected to further processing during the preparation of injectable dosage forms, the level of bacterial endotoxins are such that the requirement under the relevant dosage form monograph(s) in… Read More |
DOXORUBICIN HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DIAZOXIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In footnote a in Table 2: Change 7-Chloro-2H-benzothiadiazin-3(4H)-one 1,1-dioxide. to: 7-Chloro-2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide. |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IMPURITIES/Enantiomeric Purity | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Standard solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
ANETHOLE | DEFINITION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change (E)-1-methyl-4-(1-propenyl) benzene to: (E)-1-methoxy-4-(1-propenyl) benzene |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In System suitability solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS AND In Standard solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-… Read More |
TETRACYCLINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS/Labeling | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change Where tetracycline hydrochloride must be sterile or subjected to further processing during the preparation of injectable dosage forms to ensure acceptable levels of bacterial endotoxins, it is so labeled. to: Where Tetracycline Hydrochloride must be… Read More |
DOXORUBICIN HYDROCHLORIDE INJECTION | IMPURITIES/Organic Impurities | USPNF 2022 Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
DOXAZOSIN MESYLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of the corresponding USP Doxazosin Related Compound RS or USP Doxazosin Mesylate RS (for calculating unspecified impurities) in the Standard solution (mg/mL) to: CS… Read More |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
DOXORUBICIN HYDROCHLORIDE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change P = potency of doxorubicin in USP Doxorubicin Hydrochloride RS (µg/mg) to: P = potency of doxorubicin hydrochloride in USP Doxorubicin Hydrochloride RS (µg/mg) |
SODIUM PICOSULFATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Buffer: Change cetylrimethylammonium bromide, to: cetyltrimethylammonium bromide, |
LANSOPRAZOLE DELAYED-RELEASE CAPSULES | IMPURITIES/Organic Impurities | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | Delete Blank: Methanol and Diluent (1:9) |
TERAZOSIN CAPSULES | ASSAY/Procedure | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Hydrochloric acid solution: Change 0.1 N methanolic hydrochloric acid to: 0.01 N methanolic hydrochloric acid |
CEFTIOFUR HYDROCHLORIDE | ASSAY/Procedure | USPNF Online | Online | 30-Sep-2022 | 1-Oct-2022 | NA | NA | In Analysis: Change Calculate the percentage of ceftiofur (C19H17N5O7S3) in the portion of Ceftiofur Hydrochloride taken: Result = (rU/rS… Read More |
POTASSIUM GLUCONATE | IMPURITIES/Reducing Substances | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In Titrimetric system: Change Titrant: Iodine Back-titrant: Sodium thiosulfate to: Titrant: 0.1 N Iodine VS Back-titrant: 0.1 N Sodium Thiosulfate VS |
0.1 N Potassium Permanganate VS | STANDARDIZATION | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In Standardization with potentiometric endpoint: Change N = g Na2C2O4/mL KMNnO4 solution × 0.06700 to: N = g Na2C2O4/mL KMnO4 solution × 0.06700 |
DACARBAZINE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Suitability requirements/Signal-to-noise ratio: Change NTL 10, to: NLT 10, |
PROMETHAZINE HYDROCHLORIDE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change System suitability solution: 5 µg/mL each of USP Promethazine Hydrochloride RS and USP Promethazine Related Compound B RS from the Standard stock solution and System suitability stock solution, respectively Standard… Read More |
METHYLENE BLUE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Azure B RS: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |
METHSUXIMIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Column efficiency: Change NTL 5800 theoretical plates to: NLT 5800 theoretical plates |
PROCHLORPERAZINE MALEATE TABLETS | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In Analysis: Change Results = (AU/AS) × CS × D × (1/L) × V × 100 AU = absorbance of the Sample solution AS = absorbance… Read More |
<467> RESIDUAL SOLVENTS | USP REFERENCE STANDARDS <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change USP Residual Solvent Class 2—Mixture C RS to: USP Residual Solvents Class 2—Mixture C RS |
IRINOTECAN HYDROCHLORIDE INJECTION | DEFINITION | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change NTL 90.0% and NMT 110.0% to: NLT 90.0% and NMT 110.0% |
ECONAZOLE NITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Econazole Related Compound C RS: Change 1-(4-Chlorobenzyl)-3-{2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazol-3-ium nitrate (salt). C25H21Cl14N3O4 569.… Read More |
PROMETHAZINE HYDROCHLORIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change System suitability solution: 5 µg/mL each of USP Promethazine Hydrochloride RS and USP Promethazine Related Compound B RS from the Standard stock solution and System suitability stock solution, respectively Standard… Read More |
METHYLENE BLUE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In footnote a in Table 2: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |
MELOXICAM ORAL SUSPENSION | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Analysis: Change WU = weight of the Oral Suspension taken (mg) to: WU = weight of the Oral Suspension taken (g) |
FORSKOHLII | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
MILK THISTLE CAPSULES | PERFORMANCE TESTS/Disintegration and Dissolution <2040>, Dissolution | USPNF Online | Online | 24-Jun-2022 | 1-Aug-2022 | NA | NA | In Medium: Change Buffer containing 2% lauryl sulfate; 900 mL to: Buffer containing 2% sodium lauryl sulfate; 900 mL |
<871> SUTURES--NEEDLE ATTACHMENT | PROCEDURE | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Removable Needle Attachment: Change For USP sizes 5-0 through 2-0, to: For USP sizes 5-0 through 2, |
BACLOFEN INJECTION | SPECIFIC TESTS | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | Change • Osmolality and Osmolarity 〈785〉, Osmolality: 270–320 mOsm/kg to: • Osmolality and Osmolarity 〈785〉 Osmolality: 270–320 mOsm/kg |
POWDERED FORSKOHLII | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
MILK THISTLE TABLETS | PERFORMANCE TESTS/Disintegration and Dissolution <2040>, Dissolution | USPNF Online | Online | 24-Jun-2022 | 1-Aug-2022 | NA | NA | In Medium: Change Buffer containing 2% lauryl sulfate; 900 mL to: Buffer containing 2% sodium lauryl sulfate; 900 mL |
POWDERED FORSKOHLII EXTRACT | COMPOSITION/Content of Forskolin | USPNF Online | Online | 29-Jul-2022 | 1-Aug-2022 | NA | NA | In Chromatographic system: Change Column: 4.6-mm × 25-cm; 5-µm, 100 Å to: Column: 4.6-mm × 25-cm; 5-µm, 100 Å; packing L1 |
AMMONIUM GLYCYRRHIZATE | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change 840.08 to: 839.97 |
MELENGESTROL ACETATE | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change 396.52 to: 396.53 |
IVERMECTIN | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change C48H74O14(Component H2B1a) 875.09 C47H72O14(Component H2B1b) 861.07 Component H2B1a: Avermectin… Read More |
DOXYCYCLINE HYCLATE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE TABLETS | ASSAY/Procedure | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In Buffer: Change Adjust with phosphoric acid to a pH of 6.4 ± 0.01. to: Adjust with phosphoric acid to a pH of 6.4 ± 0.1. |
NONOXYNOL 9 | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Update the chemical structure AND Change α-(p-Nonylphenyl)-ω-hydroxynona(oxyethylene) CAS RN®: 26027-38-3. to: α-(4-Nonylphenyl)-ω-hydroxynona(oxyethylene). |
TRYPTOPHAN | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Tryptophan Related Compound A RS: Change 3,3′-[Ethylidenebis(1H-indole-1,3-diyl)]bis[2S)-2-aminopropanoic]acid. C24H26N4O4 432.49 to: (2S,2'S)-3,3'-[Ethane-1,1-diylbis(1H-… Read More |
DOXYCYCLINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
AMMONIUM GLYCYRRHIZATE | ASSAY/Content of Ammonium 18α- and 18β-Glycyrrhizate | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In Analysis: Change MW(Salt) = molecular weight of ammonium glycyrrhizate, 840.08 g/mol MW(Acid) = molecular weight of glycyrrhizic acid, 821.59 g/mol to: MW(Salt) = molecular weight of… Read More |
MELENGESTROL ACETATE | USP Reference standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Melengestrol Acetate Related Compound A RS: Change 16-Methylene-17α-hydroxy-4-pregnene-3,20-dione 17-acetate. to: 16-Methylene-3,20-dioxopregn-4-en-17-yl acetate. AND In USP Melengestrol Acetate Related Compound B RS: Change 17α-… Read More |
DOXYCYCLINE CAPSULES | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |